Treatment and Epidemiology of Acute Cerebrovascular Disease

PhD Research Mentors
Assistant Professor
Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4255
Office Phone: 513-558-8679
chellakn@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Dr. Chella Krishnan's major research focus is to understand the role of sex differences and mitochondrial (dys)function in the pathophysiology of non-alcoholic fatty liver disease (NAFLD).
One of the major complications of obesity affecting the liver, in the absence of alcohol, is NAFLD. It is estimated that 20-30% of the population worldwide are affected by NAFLD and is more prevalent in men than women, with men exhibiting severe NAFLD symptoms. Work in the K Lab is focused on understanding how host genetic background and sex differences influence the mitochondrial (dys)function and increases the susceptibility to NAFLD, and other cardiometabolic diseases such as obesity and diabetes.
The approaches we use include
1. a population-based ‘systems genetics' approach to integrate information on natural genetic variations (host genetics) with molecular phenotypes (such as gene expression, proteomics, etc.) and clinical phenotypes, with a targeted focus on sex differences and mitochondria, to identify candidate genes
2. characterizing the candidate genes in genetically modified mouse models and/or eukaryotic cell lines
3. characterizing the mitochondrial functions using a Seahorse Bioanalyzer
4. characterizing the molecular functions using RNA-Sequencing and Single Cell Genomics.
Keywords: mitochondria, sex differences, metabolism, metabolic diseases, system genetics, population genetics, fatty liver disease, obesity, atherosclerosis, hypercholesterolemia, cardiovascular diseases

Dept of Pharmacology, Physiology, and Neurobiology
Cardiovascular Research Center 5939
Office Phone: 513-558-1392
k.drosatos@uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our research investigates transcriptional regulation mechanisms that link cardiac stress with altered myocardial fatty acid and glucose metabolism. Our long-term goal pertains to the application of interventions that can improve cardiac function by modulating fatty acid oxidation and energy production.
We are interested in the role of Kruppel-like factors (KLFs) and particularly, KLF5 and its role in the regulation of cardiac fatty acid oxidation during diabetes, myocardial ischemia, ischemia/reperfusion and aging. We also investigate the role of cardiomyocyte KLF5 in regulating systemic metabolism via an undiscovered cross-talk mechanism between the heart and the adipose tissue.
Furthermore, we study the role of the cellular energetic machinery in the alleviation of cardiomyopathy in sepsis.
Keywords: metabolism, heart failure, systems biology, diabetes, ischemia, sepsis

Dept of Pharmacology, Physiology, and Neurobiology
Cardiovascular Research Center 5923
Office Phone: 513-558-2340
fangg@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our group investigates the molecular and cellular mechanisms underlying stress- and disease-induced cardiovascular remodeling. More specifically, our work focuses on macrophage function in ischemia/reperfusion-triggered heart failure, sepsis-caused cardiovascular leakage, diabetes-induced microvascular rarefaction and cardiac dysfunction. The lab uses in vivo transgenic and knockout animal models as well as in vitro primary cell culture to identify and validate novel therapeutic targets in cardiovascular disease. In addition, multiple state-of-art techniques (i.e., adenovirus-mediated gene transfer, single-cell/bulk RNA sequencing, cell sorting, flow cytometry, Co-IP, co-immunostaining, and bioinformatics) are employed to analyze the associated molecular/cellular mechanisms.
Among possible lines of investigations, we chose to focus primarily on macrophage-associated proteins (i.e., Sectm1a, Lcn10) and extracellular membrane vesicles (collected from mammalian cells or gut bacteria) in the regulation of macrophage phagocytosis, efferocytosis and polarization, endothelial permeability and cardiac contractile function, because both acute and long-term inflammation are major culprits to cardiovascular disease.
Keywords: cardiac inflammation, myocardial ischemia-reperfusion injury, vascular leakage, sepsis-induced cardiomyopathy, efferocytosis, macrophage phagocytosis, cardiac protection, cell death, endothelial cells, cardiovascular disease

Dept of Pharmacology, Physiology, and Neurobiology
Cardiovascular Research Center 5935
Office Phone: 513-558-2562
gaoc3@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
The Gao Lab is focused on uncovering novel molecular mechanisms for the pathogenesis of cardiac diseases, including cardiac hypertrophy, remodeling, and dysfunction. The lab utilizes state-of-the-art molecular, genomic, and genetic tools to discover and interrogate key molecules involved in the understudied post-transcriptional processes in RNA metabolism in cardiac tissues under physiological and pathological states. Ultimately, the lab aims to develop novel therapeutic and diagnostic strategies for heart failure and cardiometabolic diseases.
Keywords: cardiovascular disease, RNA metabolism, mouse models, molecular biology, cardiometabolic disorder, branched-chain amino acid, high-throughput sequencing, RNA splicing, RNA degradation
Professor
Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4204
Office Phone: 513-558-3115
Heinyja@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our laboratory conducts basic research on muscle physiology at the molecular and cellular levels. Recent research projects have focused on:
- The physiological roles and regulation of the Na, K-ATPase α isoforms in skeletal muscle
- Development of new technologies, based on Inductively Coupled Plasma-Mass Spectroscopy (ICP-MS) for measuring ion and nutrient transport in biological samples, including cultured cells, skeletal muscle single fibers and intact muscles
- Klf2, in the inflammatory response to injury
We use a range of experimental approaches to address this question, including: in vitro measurement of glucose uptake in isolated contracting mouse skeletal muscles of WT and TG mice; simultaneous measurement of multiple ions (K/Rb, Ca, Na, et al.) and carbon-based molecules (13C-glucose et al.) that are potentially co-transported during contraction; and immunohistochemistry assays and functional measurements of muscle force in situ and in vivo.
Keywords: skeletal muscle, K-ATPase, gastrocnemius muscle, injury, mice, muscle injury, K-ATPase α1, cell function, dihydropyridine receptor, knockout mice

Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 5259/ Reading Campus, Building A-145
Office Phone: 513-558-5636
hermanjs@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
My major research interests explore structural, functional and molecular biological principles underlying stress integration, with an emphasis on delineating mechanisms linking stress with mental illness and cognitive disorders. The organismal ‘stress response’ represents an integrated physiological process whose primary goal is to redistribute energy to meet a real or perceived challenge. As a consequence, stress engages a variety of physiological and neural processes with the ultimate objective of achieving optimal survival value, including the hypothalamo-pituitary-adrenocortical axis, the autonomic nervous system, and brain stress regulatory pathways that coordinate the behavior of the organism to fit desired outcomes. While initially adaptive, prolonged stress causes aberrant neuroplastic events in brain that have a long-term negative impact on physiology and behavior. My research is geared toward understanding the mechanisms underlying initiation of these neuroplastic events and their consequences on the individual. We have developed chronic stress paradigms that model physiological, metabolic and behavioral symptoms of depression (e.g., glucocorticoid dyshomeostasis; helplessness; anhedonia; cardiovascular pathology; visceral obesity) and PTSD (late-emerging, long-lasting potentiation of conditioned fear; late-emerging metabolic pathologies). We exploit these models to discover neurocircuit mechanisms mediating the deleterious effects of stress on neuroplasticity and behavior, focusing on corticolimbic pathways. Our work employs a broad spectrum of methods, including region/tissue-specific knockout in mice and rats; viral vector gene knockdown/ overexpression/CRISPR to modify gene expression in discrete brain regions; chemogenetic/optogenetic methods to modify brain activation in a site and projection specific manner; genomic approaches to understanding gene and epigenetic (microRNA) expression patterns in identified cell populations; mathematical modeling and bioinformatics; and state-of-the-art neuroanatomical approaches.
Keywords: stress neurobiology, behavioral neuroscience, CNS neurocircuitry: signaling mechanisms, prefrontal cortex, neurobiology of disease, computational neuroscience, multi-omics, neuropharmacology, neurophysiology, stress and cardiovascular disease

Dept of Pharmacology, Physiology, and Neurobiology
Medical Science Building 4203
Office Phone: 513-558-4159
katie.hobbing@uc.edu
CV in UC Research Directory
Graduate Director:
Applied Pharmacology & Drug Toxicology Master's Degree Program
Interim Graduate Director:
Special Master's Program (SMP) in Physiology
Keywords: educator, pharmacology, physiology, safety pharmacology, drug toxicology, drug development, career development, graduate education

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4201
Office Phone: 513-558-5093
hongca@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our long-term goal is to utilize temporal information from the circadian clock and its connections with other cellular processes (e.g. cell cycle, metabolism, etc.) to improve human health. Circadian rhythms are periodic physiological events that recur about every 24 hours. Disruption of circadian rhythms exacerbate progression of numerous diseases ranging from metabolic disorders to cancer. Despite the critical importance of circadian rhythms in human disease progression and treatments, roles of circadian rhythms in complex human diseases remain largely unknown. To achieve our goal, we seek to understand molecular mechanisms of circadian rhythms and their interconnected network with other cellular processes such as cell cycle, DNA damage response, and metabolism in order to design novel therapeutic regimens. These complex biological modules are intertwined by molecular components that communicate and adapt to various external environments to optimize the survival of an organism. We employ mathematical modeling to navigate complex dynamics of molecular networks, and use genetics and molecular biology to validate model-driven hypotheses.
Keywords: circadian clock, metabolism, cell cycle, DNA damage response, mathematical modeling, organoids, fungi, small intestine

Dept of Pharmacology, Physiology, and Neurobiology
Cardiovascular Research Center 5926
Office Phone: 513-558-2353
kirleytl@ucmail.uc.edu
CV in UC Research Directory
Description of Research:
Our research involves the following:
- Antibody Utilization, Characterization, Fragmentation, and Structure.
- Purinergic Signaling, Extracellular Nucleotides and Nucleotidases.
- Enzyme Analysis and Structure, Enzyme Inhibitors.
- Protein Expression and Refolding, Protein Engineering.
- Cysteine and Disulfide Chemistry and Analysis.
- Ligand Binding Techniques and Applications.

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4259
Office Phone: 513-558-3097
lorenzjn@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
My research has two facets. First, I am director of the Murine Physiology Core Facility in the University of Cincinnati College of Medicine. The facility is dedicated to the functional analysis of cardiovascular and renal phenotypes in mutant mice and rats. We employ a wide variety of approaches to interrogate the effects of genetic modifications in mice including acute in vivo and ex vivo diagnostic techniques as well as chronic models of cardiac hypertrophy, ischemic injury and systemic hypertension. This facility is well recognized and heavily utilized by investigators at the University of Cincinnati and elsewhere.
Second, my lab is currently engaged in research to examine the autonomic cardiovascular effects of traumatic brain injury (TBI). The ANS governs homeostatic control over different organs in the body, and is comprised of sympathetic and the parasympathetic pathways working in concert with the endocrine system to regulate cardiac, renal, adrenal, homoeothermic, and enteric function. Autonomic dysfunction can occur when there is an imbalance in the regulation or function of the parasympathetic and sympathetic pathways, resulting in cardiovascular dysfunction and failure. Thus, the overall goal of these studies is to examine the effects of TBI on the autonomic control of cardiovascular and renal function.
Keywords: cardiovascular physiology, small animal and organ physiology, functional assessment in genetic mouse models, cardiac muscle function, regulation of blood pressure, renal function, telemetric measurement of ECG/blood pressure, autonomic control, traumatic brain injury, baroreceptor function
Professor
Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4257A
Office Phone: 513-558-3627
mackenb@ucmail.uc.edu
Publications
CV in UC Research Directory
Description of Research:
Our research program is focused on the molecular physiology of iron transporters and their roles in iron homeostasis and iron disorders.
Keywords: iron transport, iron homeostasis, molecular physiology, membrane transport, intestinal iron absorption, iron disorders, Xenopus oocyte expression system, genetically modified mouse models, structure-function, voltage clamp

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4200
Office Phone: 513-558-0667
maclenaj@ucmail.uc.edu
Publications
CV in UC Research Directory
Keywords: neurophysiology, motor neuron, ciliary neurotrophic factor, CNTF, mouse model, nerve lesion
Dept. of Pharmacology, Physiology, and Neurobiology
Reading Campus, Building A-141
Office Phone: 513-558-6893
mcreynje@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our lab studies how stress facilitates or exacerbates pathological brain states and behavior, such as substance use disorder. While acute, mild stress can be beneficial for cognition and behavior, traumatic and chronic stress have deleterious effects and influence the development or severity of many neuropsychiatric disorders. This is why our lab is focused on understanding how stress can increase vulnerability in the development or severity of substance use disorders using rodent pre-clinical models of drug self-administration. We are interested in understanding how repeated stress can drive drug use and increase susceptibility for drug-seeking behavior in abstinent animals. We are focusing on the circuit-specific cellular and synaptic mechanisms that underlie this influence of stress on addiction-related behaviors. We investigate these research questions on multiple levels using complex behavioral models, such as drug self-administration, viral-mediated chemogenetic approaches, pharmacological manipulations, molecular and biochemical techniques, and neuroimaging of in vivo calcium and neurotransmitter biosensors using fiber photometry.
Keywords: neuroscience, stress, substance use disorder, addiction, mouse models, neuropsychiatric disorders
Dept of Pharmacology, Physiology, Neurobiology
Cardiovascular Research Center 5938
Office Phone: 513-558-6654
normanab@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
The focus of the Norman Laboratory is translational research to develop medications for the treatment of cocaine abuse.
Drug self-administration by animals is a valid model of human addictive behavior. It has long been considered axiomatic that drugs of abuse are self-administered because of their pleasurable (hedonic or euphoric) effects, which in turn makes these drugs positively reinforcing. Unfortunately, these assumptions result in well-known paradoxes and the idea that reinforcement plays any significant role in maintained self-administration behavior is of limited utility.
The Norman laboratory has developed a quantitative pharmacological theory of self-administration behavior in which cocaine-induced responding occurs only while drug concentrations are within a specific range. The core of our model of the maintenance phase of drug self-administration is the equation: T=ln(1+DU/DST)·t1/2/ln2, which defines the inter-injection intervals (T) in terms of only three parameters: the unit dose of cocaine (DU), the elimination half-life of cocaine (t1/2) and the satiety threshold (DST). This latter parameter is defined as the highest concentration of drug at which self-administration occurs. This simple model is the first to successfully define a seemingly complex behavior in terms of purely physical parameters.
This pharmacological paradigm represents a scientifically rigorous foundation for generating testable hypotheses about the biological basis of addictive behavior. More importantly, it provides a rational basis for the development of medications for drug addiction. To this end an active collaboration with Dr. Jim Ball has developed a human anti-cocaine monoclonal antibody as a pharmacokinetic antagonist of cocaine, which is intended as an immunotherapy to prevent relapse in cocaine abusers.
The Norman lab is also using drug self-administration behavior as a bioassay system to measure the absolute pharmacodynamic and pharmacokinetic potencies of receptor antagonists as a basis for developing antagonist based pharmacotherapies.
Keywords: pharmacology, cocaine disorder, addiction, satiety threshold, self-administration behavior, anti-cocaine antibody

Dept of Pharmacology, Physiology, and Neurobiology
Reading Campus, Building A-123
Office Phone: 513-558-8658
pereztdo@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our laboratory focuses on understanding the mechanisms involved in the neuroendocrine control of energy balance. We investigate how afferent endocrine signals, such as GLP-1, ghrelin and leptin, interact with neural circuits, specifically the melanocortin system, to regulate metabolism, and how those interactions are influenced by nutrient and environmental status. We also work on identifying the specific efferent mechanisms whereby those neural circuits in the brain control metabolism in peripheral tissues. Our technical approach is focused in the in vivo and ex vivo analysis of glucose and lipid metabolism, energy intake and energy expenditure in rodent models. In addition, we collaborate with the pharmaceutical industry to develop new therapies to treat obesity and diabetes.
Keywords: physiology, metabolism, energy balance, neuroendocrinology, melanocortin system, obesity, diabetes, ghrelin

Dept of Pharmacology, Physiology, Neurobiology
Medical Sciences Building 4206A
Office Phone: 513-558-6086
pixleysk@ucmail.uc.edu
CV in UC Research Directory
Lab Home Page
Description of Research:
Dr. Pixley’s lab coordinates with an interdisciplinary group that spans UC colleges, US universities, international partners and industrial partners. For over 10 years, this work has been part of an NSF Engineering Research Center (ERC) funding mechanism. This ERC was entitled Revolutionizing Metallic Biomaterials. Three US universities, several industrial partners and an international partner were involved. The Pixley lab focus has been on novel applications of metallic biomaterials, particularly to repair damaged nervous tissues. The particular application pursued to date has been peripheral nerve regeneration. While the ERC funding has now ended, the lab continues its partnership with engineers to advance biomedical repairs. Our most recent partnership is with an engineering team in Israel.
When substantial injuries occur that result in complete loss of peripheral nerve segments, surgical intervention is required. A scaffold is used to replace the lost segments and reconnect the two cut nerve endings. We seek to develop “man-made” or biomaterial scaffolds to avoid the hazards and dangers of using autografts (nerves from the same patient). In particular, we are interested in using a unique material, biodegradable metals (magnesium (Mg) and zinc (Zn)) as part of scaffolds. These metals have promise to provide a physical pathway to safely guide and support regenerating cells as they cross an injury gap in a nerve and regenerate a nerve segment.
Our research has shown that Mg and now Zn metal, in microfilament forms, have great promise to provide this type of contact guidance. Our goals now are to continue to refine the use of these biomaterials, as well as to develop a better understanding of the mechanisms by which nerve regeneration adapts to these unusual biomaterials, as a means to understand nerve regeneration and nerve repair in general.
Techniques used in the lab involve animal surgery, behavioral studies and then histological analyses. We also use cell culture to study the cellular responses to the metals, their ions and other degradation products.
Keywords: tissue regeneration after injury, peripheral nerve regeneration, skin wound healing, biodegradable metals, nerve repair scaffolds, tissue implants and engineering, foreign body tissue responses, Schwann cells, rodent cell culture and in vivo experiments, tissue implants and engineering

Dept of Pharmacology, Physiology, Neurobiology
Reading Campus, Building A-129
Office Phone: 513-558-4338
reyesta@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Dr. Teresa Reyes examines the effects of early-life adversity on behavior and cognition in mice, with a focus neural-immune interactions. Current projects in the lab investigate (1) the mechanism by which chemotherapy leads to cognitive deficits in survivors of childhood leukemia, (2) how maternal opioid use affects cognition and behavior in exposed offspring, and (3) how diet shapes brain development. Advanced operant testing is used to assess executive function (e.g., attention, impulsive behavior, cognitive flexibility) and the lab is also interested in examination of sex differences.
Keywords: neuroscience, neurodevelopment, behavior, cognition, mouse model, neuron-glia interactions, transcriptomics, adverse early life, sex differences

Dept of Pharmacology, Physiology, and Neurobiology
Reading Campus, Building A-133
Office Phone: 513-558-5129
sahr@ucmail.uc.edu
CV in UC Research Directory
Lab Home Page
Description of Research:
The Sah laboratory is interested in understanding mechanisms that promote vulnerability to psychiatric disorders. We are focusing on threat and fear associated conditions such as posttraumatic stress disorder (PTSD) and panic disorder (PD). The prevalence of these disorders is on the rise due to an increase in life traumas ranging from combat to COVID.
As humans, we consistently encounter traumatic experiences, some of which may signal a threat to survival. Fear, a normal adaptive response to threat can become maladaptive in certain individuals resulting in abnormal threat detection and persistent fear memories promoting symptoms of panic and PTSD. We are interested in finding out “what” promotes abnormal fear regulation and “why” some individuals have deficits in processing fear. We use translationally relevant rodent models and translational approaches aligned with the National Institute of Mental Health RDoC criteria (https://www.nimh.nih.gov/research/research-funded-by-nimh/rdoc/about-rdoc). Although our research is fear-centered, we also investigate stress, anxiety, learning-memory and depression relevant behaviors in our models.
In the past several years the Sah group has made several seminal discoveries on novel target proteins and mechanisms that signal threat sensing and generation of fear. We established the relevance of stress resiliency neuropeptides in PTSD as well as an unprecedented role of immune signaling in panic genesis. Over the years, our lab focus has moved from being “brain-centric” to appreciating the “body and the brain”. A primary interest centers on understanding how peripheral signals can regulate threat responding and fear. As an example, we are trying to understand how chronic inflammation associated with asthma can regulate fear processing to other traumatic experiences. We are also exploring specialized brain areas located near the ventricles in body-to-brain signaling of threat and fear generation.
The immediate goals for these projects are to a) understand fear genesis to both external triggers as well as homeostatic “within the body” signals, b) identify novel targets that regulate fear learning and memory of relevance to PTSD and PD, and c) understand pre-trauma predisposition factors that promote susceptibility to psychiatric illness. The long-term goal is to identify novel and effective therapeutic targets and predictive biomarkers for PTSD and PD.
If you are interested in our research, please contact us (sahr@uc.edu). We welcome motivated, curious, and hard-working individuals in our group!
Keywords: PTSD, panic disorder, abnormal fear, stress resiliency neuropeptides, neuroendocrinology, body-to-brain signaling, rodent models

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 5157
Office Phone: 513-558-9754
schuljo@ucmail.uc.edu
CV in UC research Directory
Graduate Director: Molecular, Cellular, & Biochemical Pharmacology PhD Degree Program and System Biology and Physiology PhD Degree Program
Description of Research:
The interests of my research program are to elucidate the signaling mechanisms involved in cardiac pathophysiology, especially in relation to cardioprotection (heart protecting itself against injury due to ischemia) and heart failure. Our approach involves the utilization of transgenic and gene-targeted mice with pertubations of specific receptors, endogenous factors, and signal transduction cascades in the heart. This allows us to relate changes in the action of single gene products with specific alterations of cardiac biochemistry, physiology and pathophysiology in vivo. Both in vivo and in vitro physiological approaches are utilized in my lab to elucidate the contribution of the opioid and growth factor receptor systems to cardiac pathophysiology. We routinely employ echocardiography, work-performing and Langendorff whole heart preparations, in vivo hemodynamic measurements, and isolation and analysis of cardiomyocytes. In addition, a number of surgical techniques (aortic banding, coronary artery ligation, catheterizations) are used in my laboratory. Throughout these studies, pharmacological, histological, biochemical, and state-of-the art molecular biology assays are employed, and include PCR for mouse genotype determination, Northern blot and quantitative real-time PCR analysis of mRNA expression, and protein analysis via Western blot, ELISA and immunostaining. Genomic and proteomic tools, including DNA microarrays, will be implemented in the lab to further characterize or identify known and novel mechanism(s) of opioid- and growth factor-mediated cardiovascular physiology and pathology.
Keywords: cardiovascular, growth factors, opioids and opiates, ischemia, vascular growth, heart failure

Dept of Pharmacology, Physiology, and Neurobiology
Reading Campus, Building A-143
Office Phone: 513-558-2709
timmens@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Research in our laboratory is focused on understanding the neural computations underlying decision-making and how they malfunction. Specifically, we are most interested in understanding the causes of aversion-resistant alcohol drinking and finding treatments for this key component of alcohol use disorder (AUD, “alcoholism”). People who suffer from AUD frequently drink alcohol despite negative consequences. Our lab seeks to identify and repair alterations in the neural circuits that govern the decision to drink which produce this behavior.
In pursuit of these goals, we employ pre-clinical rodent models and in vivo electrophysiology to examine neural computations during decision-making. We also utilize advanced data analysis techniques, including machine learning and computational models to analyze the data. We also utilize optogenetic and chemogenetic techniques to modify neural behavior.
In the future, we will expand our studies to include the roll stress plays in aversion-resistant drinking, we will examine other types of addiction (both addictions with (e.g., opioids) and without (e.g., gambling) exogenous pharmacological elements), and we will pursue more advanced computational modelling approaches to improve treatment predictions.
Keywords: prefrontal cortex, alcohol drinking, alcohol use disorder, medial prefrontal cortex, neural activity, aversion-resistant drinking, brain regions, cortex, information theory, negative consequences

Dept of Pharmacology, Physiology, and Neurobiology
Reading Campus, Building A-143
Office Phone: 513-558-6118
ulrichym@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our research goal is to identify the neural and hormonal substrates that are responsible for the interactions among diet, obesity, and stress. Obesity is a major health problem affecting 30% of adults in the United States. Despite public health efforts to combat obesity, it continues to rapidly increase in incidence, along with obesity-related diseases and health costs. Similarly, stress-related psychiatric disorders, including depression and anxiety, affect large segments of the population and place a substantial toll on patients, families, and communities. Notably, there is a high co-morbidity between obesity/metabolic disorders and stress-related psychiatric disorders, supporting the idea that there are complex interactions among stress, obesity, and diet. For instance, stress generally increases the intake of palatable ‘comfort’ foods (which can promote obesity), and the ingestion of these foods improves mood and decreases emotional and behavioral responses to stress. However, the mechanisms underlying these interactions among are unknown, and this knowledge is needed to identify novel therapeutic targets for the prevention and treatment of obesity, as well as other stress-related disorders.
Keywords: behavior, stress, obesity, diet, reward, brain, hormones, metabolism, neural circuits, corticosterone

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 5151A
Office Phone: 513-558-2379
wanghs@ucmail.uc.edu
CV in UC Research Directory
Lab Home Page
Description of Research:
Our lab studies the cardiovascular system. We are interested in how normal cardiac physiology is governed by various cardiac ion channels, and how cardiac electrical properties are altered in disease conditions or by environmental chemicals. In particular, we are interested in how a group of environmental chemicals called “endocrine disrupting chemicals” may alter the normal electrical and mechanical properties of the heart. Our past studies systematically examined the impact of a common environmental chemical, bisphenol A or BPA, and its related analogs, on the heart, and showed that these chemicals can increase the risk of cardiac arrythmias. Further, we elucidated the signaling, receptor, molecular and pharmacokinetic mechanisms underlying the actions of these chemicals. Currently we are examining the cardiovascular toxicity of a broader range of environmental chemicals using animals models, human stem cell-derived cardiac myocytes, and human cohort biosamples. We also study cardiac ion channels and cardiac electrical properties. A current focus is how a type of proton channels contributes to acid extrusion and pH regulation in the heart.
Keywords: cardiovascular system, ion channels, bisphenol A, arrythmias, cardiac myocytes, pH regulation

Dept of Pharmacology, Physiology, and Neurobiology
Reading Campus, Building A-121
Office Phone: 513-558-6870
wohlebes@ucmail.uc.edu
Publications
CV in UC Research Directory
Lab Home Page
Description of Research:
Our research group studies how neuroimmune systems shape synaptic function and behavior in pathological and physiological conditions. To this end, we use multi-disciplinary approaches, including flow cytometry and cell sorting, cell type-specific molecular analyses (RNA-Seq), viral-mediated genetic and pharmacological manipulations, and imaging techniques to study pathways mediating neuro-immune interactions.
We strive for scientific excellence and integrity; and we value a supportive work environment that fosters provocative ideas and collective efforts to achieve goals.
Keywords: microglia, neuroplasticity, stress, psychoneuroimmunology, DNA breaks, neuropharmacology, electrophysiology, glia

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4251
Office Phone: 513-558-6489
worrelrt@ucmail.uc.edu
Publications
CV in UC Research Directory
Graduate Director: Systems Biology and Physiology PhD Degree Program
Description of Research:
My research focuses on understanding the factors influencing epithelial transport, particularly in the GI track.
Keywords: physiology, epithelium, transport, Ussing chamber, chloride, educator, mucus, intestine

Dept of Pharmacology, Physiology, and Neurobiology
Medical Sciences Building 4260
Office Phone: 513-558-6156
zhangtl@ucmail.uc.edu
Publications
CV in UC Research Directory
Description of Research:
Cells, working machines in our body, respond to environmental signals (e.g. food, hormone, and infection, etc.) and make critical decisions such as proliferation, differentiation, defense, or even death.
The decision makings of cells are carried out by their molecular control networks. Although no single molecule is directing the cellular behaviors by itself, the dynamical properties emerging from the interaction between the control molecules serve as clear commands to the cells.
As we know more about the molecular control networks, they are getting more complex. These networks often include feedbacks, crosstalk, context-dependent changes, and time-dependent changes. Mathematical modeling is a powerful tool to handle such complexities.
In my research, I combine biological intuition with mathematical modeling to make clear the seemingly confusing networks. My biological intuition is on cell cycle, apoptosis, p53 pathway and NF-κB pathway. My modeling expertise is on positive feedbacks, negative feedbacks, switches, and oscillations.
Interested students are encouraged to send me CVs and discuss opportunities in my group.
Keywords: quantitative systems pharmacology, machine learning, neural network, artificial intelligence, model informed drug development, digital twins, matlab, python, nonlinear dynamics, computational biology

Dept of Dermatology
Medical Sciences Building 7165
Office Phone: 513-558-6246
abdelmza@ucmail.uc.edu
Publications
CV
Description of Research:
The Abdel-Malek laboratory is internationally known for its contributions to the understanding of the regulation of human pigmentation and the response of human melanocytes to solar ultraviolet radiation, the major causative factor for skin cancers, including melanoma. Research in her laboratory is focused on investigating melanoma susceptibility and prevention, and the role of keratinocyte- and fibroblast-derived factors in regulating DNA repair mechanisms in melanocytes. Her seminal research on melanocortins and the melanocortin 1 receptor led to the development of small peptide agonists of the receptor that stimulate pigmentation and enhance repair of DNA damage resulting from exposure to ultraviolet radiation. This translational project promises to yield a novel and effective skin cancer prevention strategy.
Dr. Abdel-Malek has assumed leadership roles in the Pigment Cell Societies and Society of Melanoma Research. She has trained many graduate, undergraduate, and medical students, and postdoctoral fellows, and hosted many international visiting scientists. Her research has been continuously supported by federal grants from NIH, Department of Defense, and the Veterans Administration, and by non-federal national and institutional grants, and industry funding. Her research has been enriched by multidisciplinary collaborations with leaders in the fields of pigment cell and melanoma research nationally and internationally, and with UC researchers from other colleges and departments. Dr. Abdel-Malek is a member of the UC Cancer Center and the UC Center for Environmental Genetics.

Dept of Pediatrics
Children's Hospital Building S10
Phone: 513-636-4200
sandra.andorf@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The Andorf Lab primarily focuses on computational approaches in the intersection of immunological and clinical research to study underlying causes and novel approaches for the prevention, diagnosis and treatment of disease. Most of our research is in the field of food allergy. However, we also study other immune-mediated disorders. Our projects often involve the analysis of single-cell data from assays such as flow cytometry (FCM) or mass cytometry (CyTOF), and much of our work is collaborative with experimental biologists, clinicians and biostatisticians.
A secondary focus of the Andorf Lab is the reuse of individual-level clinical study data. For this research, we leverage data that are available in the immunology database and analysis portal (ImmPort) and other similar resources.

Dept of Pediatrics - Biomedical Informatics
Children's Hospital Building R
Office Phone: 513-636-4865
bruce.aronow@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The Aronow Lab focuses on collaborative research projects and the development of informatics systems that leverage multiple disciplines of knowledge, expertise and diverse data. The goal is to improve our collective ability to formulate high-impact inferences, hypotheses and next-stage experiments that could have the highest overall impact for biomedical research. We currently focus on finding or supporting efforts to solve problems relevant to genomic medicine by developing, both independently and collaboratively, new algorithms, tools and methodologies in translational bioinformatics. To this effect, we deal with several aspects of bioinformatics, ranging from gene regulatory networks to systems biology of normal and perturbed states.

Dept of Anesthesiology
Medical Sciences Building 3412
Office Phone: 513-558-5037
bacceiml@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
Although infants and children experience pain as the result of injury, disease, surgery or intensive care therapy, pediatric pain remains undertreated and poorly understood. Efforts to design new, evidence-based treatments for chronic pediatric pain have been hampered by a lack of information regarding how neonatal pain circuits respond at a cellular and molecular level to tissue damage or other forms of early life adversity. My lab is currently characterizing the short- and long-term effects of early life adversity on developing sensory neurons and synaptic networks located within the superficial dorsal horn of the spinal cord, which serves as an important relay station in the pain pathway. Experimental approaches include ex vivo electrophysiology in rodent dorsal root ganglia and spinal cord slices, 3D confocal microscopy, immunohistochemistry, in situ hybridization, RNA-sequencing, and behavioral measurements of pain sensitivity. It is our hope that by identifying age-specific changes in the functional organization of pain networks under pathological conditions, this work will yield new insight into the underlying basis for hyperalgesia during the early postnatal period and also help explain why neonatal tissue damage appears capable of altering pain perception throughout life.

Dept of Pediatrics - Allergy
Children's Hospital Building S6.409
Office Phone: 513-636-1851
artem.barski@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The Barski Lab researches epigenomics with a primary focus on the immune system. Our main research projects are designed to investigate epigenomic regulation of T-cell differentiation, activation and memory.
To support these projects, we run a complete “-omics” kitchen, including both wet lab “-omics” biotechnology and dry lab data analysis. Our expertise in both areas has led to multiple collaborative papers and grant applications on topics ranging from the epigenomics of spermatogenesis to the epigenomics of atopic disease to epigenomics of lung development. Dr. Barski is also a co-founder of a startup, Datirium, LLC, which developed Scientific Data Analysis Platform, SciDAP is used for analysis of various NGS data including bulk and single cell transcriptomics and epigenomics data.

Dept of Chemistry
Crosley 1301
Office Phone: 513-556-4886
becktl@ucmail.uc.edu
CV
Description of Research:
- Theory and computer simulations of liquids.
- Development of multiscale methods for electronic structure.
- Electron transport in molecular electronics
- Modeling of biological ion channels.
- Fundamental studies of ion hydration and specific ion effects.
- Solvation Science,
- Statistical Mechanics.
- The Energy Sciences.

Dept of Biological Sciences
A&S Biological Sciences Room 711D
Office Phone: 513-556-9714
benoitja@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
Mechanisms underlying insect stress tolerance, reproductive physiology, regulation of metabolism and aging are the encompassing themes of my research, with the goal of integrating these topics under whole system studies that use molecular-, organismal- and population-based approaches. The emphasis of my lab is on producing broadly-trained biologists that have knowledge and experience in a variety of techniques, allowing proficiency in bioinformatics, laboratory techniques and field research. Although individuals within my lab are not limited to a specific insect system, there is a slant toward medically-important insects/arthropods such as mosquitoes, tsetse flies and ticks.

Insect reproductive physiology. Insect reproduction varies from oviparity (egg production) to viviparity (birth of live young). The main point of this research is on factors that influence egg production (mosquitoes, bed bugs) and production of live young (tsetse flies, cockroaches). Research on tsetse flies and cockroaches focuses on the mobilization of maternal nutrients from stores to feed developing progeny within the mother, a process known as insect lactation. The goal of these studies are to identify reproductive bottlenecks that could be used as targets for control of pestiferous insects. Individuals focusing on this topic will have a broad understanding of the molecular mechanisms of reproductive physiology.
Mechanisms of stress tolerance in insects. The ability of an organism to tolerate and respond to stress is critical to its establishment and persistence in specific localities. The objectives of this research are to identify mechanisms utilized at multiple biological levels (molecular to population) by insects to prevent and recover from stress. Projects investigating these responses range from direct measurement of insect stress tolerance to functional genomics and metabolomic analyses. When possible field studies will be integrated into these projects to assess if mechanisms identified in the laboratory can be confirmed in natural populations. Individuals working on these projects will have extensive knowledge of molecular mechanisms utilized by insect to prevent stress-induced damage and techniques necessary to investigate these mechanisms.
Regulation of nutrient storage and breakdown. Maintenance of nutrient levels is critical for organisms to maintain adequate body mass so they can function properly. This research focuses on the role of insulin and other hormones in relation to the regulation of nutrient levels during progeny production, stress and starvation. Projects involve the utilization of basic techniques of insect endocrinology and expand to the determination of large-scale transcript and proteome changes. Two specific goals for this research: 1. determine the role of nutrient homeostasis during insect reproduction to reduce the fecundity of pest insects, and 2. identify factors that are similar among animals to promote insects as models for metabolic diseases.
Aging. Aging and death are processes that affect every organism. The process of aging is influenced by a multitude of factors including the genotype, stress exposure and reproduction. The encompassing goal of the research topic is to determine how stress and reproduction alter longevity and fecundity. Specific topics include mechanisms by which individuals prevent damage at the molecular and organismal levels.

Dept of Neurology
One Stetson Square 5221G
Office Phone: 513-558-0192
broderjp@ucmail.uc.edu
Publications
CV
Description of Research:

Dept of Pediatrics-Dev Biology
Children's Hospital Building R
Office Phone: 513-636-4200
cristina.cebrian@cchmc.org
Publications
CV
Description of Research:
My laboratory studies the cellular and molecular mechanisms driving kidney development; the mechanisms that, when they go awry, can cause Congenital Anomalies of the Kidney and the Urinary Tract (CAKUT). These anomalies, that range from common defects such as vesicoureteral reflux to severe malformations such as renal agenesis, represent about 30% of all prenatally diagnosed malformations. Our overarching goal is to identify the mechanisms that drive renal progenitor cell self-renewal and differentiation and the pathological outcomes of disrupting these processes.
In addition, we are unraveling the earliest events leading to cystogenesis in Autosomal Dominant Polycystic Kidney Disease (ADPKD). This is the most common monogenic disease leading to kidney insufficiency and affects 12.5 million people worldwide. Our research aims at understanding the cellular behavior of mutant cells at the inception of cyst development, with the ultimate goal of identifying early therapeutic interventions.
We use both mouse models and human pluripotent stem cell lines that we differentiate into kidney organoids to answer these questions. Among our most common tools, we use transcriptomics and advanced imaging including whole kidney clearing and time-lapse confocal imaging.

Dept of Internal Medicine - Nephrology & Hypertension
Medical Sciences Building 6115
Office Phone: 513-558-5471
conforl@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
My laboratory specializes in immune cell function and the mechanisms that control the ability of T and NK cells to perform effector functions in the context of cancer and autoimmunity. Our research focuses on ion channels and the membrane mechanisms that regulate the activation and function of these cells. Ion channels, located on the membrane of immune cells, regulate calcium homeostasis and associated effector functions and gene expression.
Our main focus areas are:
1. Role of ion channels in immune surveillance and the response to immunotherapies in cancer patients. This research focuses on the role of the tumor microenvironment (TME) in cancer immune escape and the resistance to immunotherapies. We have discovered that ion channels control the anti-tumor capabilities of cytotoxic T cells and mediate the immunosuppressive effects of hypoxia, adenosine, PDL1 in the TME. We recently discovered that these channels are involved in the resistance to immune checkpoint therapies. These studies have contributed to establishing ion channels as new elements of immunosuppression in cancer and have opened new venues for investigation targeted toward developing novel cancer immunotherapies. Lately, we have expanded our research interest to exosomes, important immune suppressive mediators of the TME.
2. Role of ion channels in human T lymphocyte dysfunction in autoimmunity and infectious diseases. Systemic Lupus Erythematosus (SLE) is an autoimmune disease that affects predominantly women and is characterized by a broad variety of clinical symptoms such as glomerulonephritis and central nervous system impairment. We have shown that human T lymphocytes of SLE patients present with a characteristic defect in potassium channel behavior. Recently, we have extended our studies to COVID-19, where an exaggerated T cell function is associated with the cytokine storm, an excessive production of proinflammatory cytokines that contributes to acute lung damage and death. We discovered that T cells of severe COVID-19 patients have an increased expression of Kv1.3 channels and that dexamethasone’s beneficial effects in COVID-19 can be in part ascribed to its ability to suppress T cell function via Kv1.3 channel inhibition. These studies emphasize the therapeutic potentials of ion channel blockers in autoimmunity and COVID-19.
3. Development of nanoparticle-based targeted therapy in autoimmunity and cancer. Our ultimate goal is to develop new therapeutics that suppress the activity of T cells in autoimmunity and increase the activity of T cells in cancer. To this end, we have developed a novel therapy for SLE that selectively inhibits memory T cells by knock-down of Kv1.3 channels. We have fabricated functionalized lipid nanovesicles for siRNA delivery. We showed that these nanoparticles effectively prevented the development of lupus nephritis in a humanized mouse model of the disease. We are now applying a similar approach to cancer with the fabrication of lipid nanovesicles for mRNA delivery in adaptive immune cells that can block the immune suppressive effects of the TME via ion channel upregulation.

Dept of Neurosurgery
Children's Hospital Building S3.421
Office Phone: 513-803-9275
steven.crone@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The Crone Lab investigates how neural circuits that control breathing are altered by disease and injury. A variety of approaches are used to study the control of breathing in transgenic mice at the level of the whole animal (plethysmography, electromyography), neural circuit (synaptic tracing, 3D imaging, chemogenetics) and individual molecules (RNA sequencing).
We are working to develop new approaches to repair or enhance the function of respiratory circuits to improve breathing in patients with spinal cord injury, epilepsy, and neuromuscular diseases such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA) and muscular dystrophy.
Our lab is also actively involved in the Neuromuscular Development Group. Our collaborations aim to accelerate research in the development and diseases of the neuromuscular system.
Professor
Dept of Cancer & Cell Biology
Vontz Center 3304
Office Phone: 513-558-1957
czyzykm@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
Kidney cancer affects annually 300,000 worldwide and 65,000 in USA, with 100,000 and 14,000 deaths respectively. Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. ccRCC is characterized by mutations in several tumor suppressors positioned on the short arm of chromosome 3 (3p), including VHL, PBRM1, BAP1 and SETD2. Our laboratory has been working in the field of ccRCC and VHL for the past several years. We are investigating three important areas in ccRCC pathobiology: (1) Using metallomics and metabolomics as well as molecular and biochemical approaches we investigate the role of copper in metabolic reprogramming during progression of ccRCC. (2) Using molecular and biochemical approaches we interrogate mechanisms of tumor promoting and tumor suppressing autophagy and connections between autophagy and cancer metabolism. (3) Using systems biology approaches we investigate genomic, transcriptomic, metabolomic subtypes of ccRCC and the role of environmental factors such as metals and tobacco smoking in the etiology of these subtypes.
Associate Professor
Dept of Pediatrics
Children's Hospital Building R
Office Phone: 513-636-0286
senad.divonovic@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The overall goal of my research program is to define the fundamental processes, mechanisms and immune pathways underlying disease pathogenesis, with an ultimate goal of translational exploitation of such insights for eliminating/reducing burdens of inflammatory/metabolic/infectious diseases.
My research interests are directly coupled to my expertise in various pathways that regulate immune responses— developed via reductive analysis of both innate and adaptive immune responses (e.g., TLR, BAFF, type I IFN, IL-17 signaling) in animal models of standard and thermoneutral housing and various infections— have positioned our group ideally to examine cellular and molecular processes that regulate immunopathogenesis of various disease. Further, our experimental model findings are supported by established and ever developing platforms of primary human samples/tissues from individuals clinically stratified into respective disease categories (collaborations with physicians/clinical scientist).
Specifically, the current focus of my laboratory is to exploit novel immune pathways underlying: (i) maternal obesity associated vertical transmission of adverse offspring health outcomes; (ii) infection/inflammation driven regulation of parturition; (iii) metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis; (iv) obesity development and adipocyte-immune like behavior; and (v) obesity-associated infectious insult and asthma susceptibility.
Associate Professor
Dept of Cancer & Cell Biology
Vontz Center
Office Phone: 513-558-5343
fanyb@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
The long-term goal of our research is to explore the molecular basis of vascular disease and the intersection of vascular disease and cancer. We aim to uncover novel therapeutic targets and approaches to prevent and treat cardiovascular disease and cancer.
We recently demonstrated that transcription factor EB (TFEB), a master regulator of autophagy and lysosome biogenesis, is critical to maintain vascular wall homeostasis. The overall goal of the Fan laboratory is to identify novel therapeutic targets for the treatment of a variety of vascular-related human diseases.

Dept of Pediatrics
Children's Hospital Building R
Office Phone: 513-636-4200
john.hogenesch@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
John Hogenesch, PhD, is a genome and circadian biologist focusing on the genetics of circadian timing in mammals.
He discovered Bmal1, the master regulator of the mammalian clock, but also its paralog Bmal2, its partner Npas2, and the positive loop of the clock (Hogenesch et al., JBC, 1997; Hogenesch et al., PNAS, 1998; Hogenesch et al., J. Neurosci, 2000).
Later, his lab characterized Rora/Rorb/Roc as key regulators of Bmal1 and circadian function (Sato et al., Neuron, 2004), discovered Chrono as a non-canonical repressor of Bmal1/Clock (Anafi et al., PLoS Biology, 2014), and Kpnb1 as a required transporter of the PER/CRY complex (Lee et al., Elife, 2015).
The Hogenesch lab studies transcriptional outputs of the clock in animal models and humans (Panda et al., Cell, 2002, Hughes et al., PLoS Genetics, 2009, Zhang et al., PNAS, 2014; Anafi et al., PNAS, 2017; Ruben et al., Science Translational Medicine, 2018). This work is leading to a wealth of new opportunities in circadian medicine and has spurred community contributions, such as the public databases the Gene Atlas and Gene Wiki, CircaDB, and algorithms, including JTK, PSEA, MetaCycle, and CYCLOPS (Su et al., PNAS, 2004; Huss et al., NAR, 2010; Hughes et al., JBR, 2010; Pizarro et al., NAR, 2013; Zhang et al., JBR, 2014; and Wu et al., Bioinformatics, 2016; Anafi et al., PNAS, 2017).
Together with collaborators at Cincinnati Children's ( David Smith, MD, PhD, Thomas Dye, MD, Kelly Byars, PsyD, Danielle Graef, PhD and Carlos Prada, MD), the Hogenesch lab is also characterizing genetic variation in syndromic and non-syndromic children with circadian sleep disorders.

Department of Internal Medicine - Cardiology
Cardiovascular Research Center Room 3935
Office Phone: 513-558-5675
hollanck@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
Bioeffects of Diagnostic and Therapeutic Ultrasound
Acoustic Cavitation
New Diagnostic imaging Techniques for the Early Detection of Vascular Disease and Ischemic Injury to Brain

University Distinguished Research Professor
Department of Pathology & Laboratory Medicine
Reading Campus
2180 East Galbraith Road, A-257
Office Phone: 513-558-9152
david.hui@uc.edu
Publications
CV
Lab Home Page
Description of Research:
Lipid Metabolism, Atherosclerosis, Diabetes, Obesity, Vascular Biology
Our research program focuses on three specific areas relating cholesterol metabolism with individual susceptibility for coronary heart disease.
Particular emphasis is placed on the genetic factors that are important for regulation of cholesterol transport and in the maintenance of cell functions in the arterial wall.
One area of research uses induced mutant mice (transgenic and knockout mice) to determine the role of lipolytic enzymes and intestinal cell surface transporters in mediating dietary fat and cholesterol absorption through the gastrointestinal tract.
Mutant mice generated from these studies are also being used as an animal model to explore the potential of gene therapy as treatment for nutrient malabsorption due to pancreatic insufficiency. The mechanism by which the lipolytic enzymes and transport proteins mediates cholesterol absorption is being explored using protein chemistry and site specific mutagenesis approaches.
The second area of research uses tissue cell culture and transgenic mice to identify the interactive effects between diet and genetic factors in the maintenance of plasma cholesterol level and determination of atherosclerosis risk.
The current emphasis is focused on the role of cholesterol esterase, apolipoprotein (apo) E, LDL receptor, HMG-CoA reductase, and other hepatic lipoprotein receptors in determining individual susceptibility to diet-induced hyperlipidemia and atherosclerosis.
Major effort in the laboratory is also spent on the third project, which is to determine the molecular and cellular events in the arterial wall in response to injury, such as those observed in human subjects undergoing balloon angioplasty.
A mouse model of arterial injury has been established in the laboratory for this purpose. This model will be used to explore cell signaling mechanisms of arterial smooth muscle cell hyperplasia. Genetic factors that may contribute to or limit the vascular cell responses after injury will be identified by genetic approaches.
Particular emphasis is placed on testing the hypothesis that apoE has cytostatic functions in the vessel wall, limiting arterial smooth muscle cell hyperplasia after injury, and that apoE gene transfer to the vasculature may be a potential therapeutic treatment to reduce the risk of restenosis after balloon angioplasty.

Department of Pediatrics - Hematology
Children's Hospital Building R
Office Phone: 513-636-0989
theodosia.kalfa@cchmc.org
Lab Home Page
Description of Research:
Our laboratory is studying signaling within the erythroid progenitor and precursor cells during erythropoiesis, as well as in mature red blood cells. We specifically focus on signals conducted by Rac GTPases, which are members of the Rho family and Ras superfamily. They switch between the inactive GDP-bound form and the active GTP-bound form to regulate a wide spectrum of cellular functions. They have been shown to play unique and overlapping roles in hematopoietic and blood cells (Mulloyet al., Blood. 115:936–947. 2010). They control actin cytoskeleton, cell motility, vesicular transport pathways, reactive oxygen species production, as well as cell adhesion and migration, proliferation and survival.
We explore the role of Rac GTPases in erythropoiesis and mature RBCs in gene-targeted mice where Rac1 and Rac2 GTPases have been deleted from the hematopoietic cells. We also study the role of Rac GTPases in generation of reactive oxygen species (ROS) within human erythrocytes from patients with sickle-cell disease.

Department of Pediatrics
Children's Hospital Building R
Office Phone: 513-636-4259
jennifer.kaplan@cchmc.org
CV
Lab Home Page
Description of Research:
Sepsis is a response to infection that can lead to a massive and dysregulated systemic inflammatory response resulting in multiple organ dysfunction and death. Although treatment with antibiotics treats the underlying infection, it does not reverse the cascade of signaling events activating the inflammatory responses. There are few interventional trials demonstrating clinical benefit in patients with sepsis. The Kaplan Laboratory is dedicated to understanding and treating the inflammatory responses in sepsis by using a basic, translational and clinical research approach.
Our research focuses on three main areas:
- The Role of PPAR gamma in Sepsis.
- The Increased Susceptibility of Diet-Induced Obesity to Sepsis.
- Phase 1 Clinical Trial of Pioglitazone in Pediatric Sepsis.

Department of Immunobiology
Children's Hospital Building R
Office phone 513-636-3999
ian.lewkowich@cchmc.org
CV
Lab Home Page
Description of Research:
The research in Lewkowich lab focuses on identifying the mechanisms through which a variety of conditions or exposures can alter the development and/or severity of allergic asthma. Many of the factors the lab are interested in are those that are present primarily in early life, and have a long-lasting effect on asthma outcomes, even later in life. These include things like early life exposure to allergens (even exposure of the mother, or the father, prior to conception), or dysbiosis induced by maternal exposure to antibiotics. The lab has also recently developing a unique model of asthma in obese mice that recapitulates many of the features of the “obese asthma” endotype observed in humans (including more severe asthma, a shift away from the normal “Th2-dominated” inflammatory profile to a “mixed Th2/Th17 inflammatory profile”, and a marked female bias). We are currently exploring the mechanistic underpinning of how these exposures modify the immune responses underlying asthma, with a hope to identify therapeutic targets that can be used to mitigate, or reverse the impact of these exposures. Work is also being done to identify how factors uniquely associated with each of these exposures/conditions alters the “normal” asthma pathways, and contributes to the development of more severe asthma.
Research in the lab uses a combination of in vitro approaches and in vivo animals models, and seeks to apply findings from these models to samples collected from pediatric donors with asthma complicated by a variety of conditions.”

Department of Mathematical Sciences
4199 French Hall West
Office Phone: 513.556.4127
limsg@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
My expertise centers on mathematical modeling, computer simulations, numerical algorithm development, and dynamical process analysis, particularly within biological and physical realms. Currently, my research is primarily focused on investigating bacterial swimming mechanisms, nonlinear dynamics within coupled biological systems, and tumor growth and invasion patterns in brain and breast cancer. I work on advancing mathematical models, validating them through biological experiments, and proposing avenues for further experimental exploration.

Department of Pediatrics
Children's Hospital
3333 Burnet Avenue
Office phone 513-636-7684
richard.lu@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
Recent studies indicate a convergence between neural developmental processes, neurological disorders and brain tumorigenesis whereby insight into one yields insight into the others. We are interested in understanding how distinct glial cell types (e.g., myelinating oligodendrocytes) and their stem / progenitor cells contribute to neurological diseases and how dysregulated developmental programs play a role in tumorigenesis both in the central (CNS) and peripheral (PNS) nervous systems.
A major focus of our lab is to elucidate the transcriptional, posttranscriptional, epigenetic, and signaling networks that govern development, remyelination, and tumor formation in the CNS and PNS. We have established a series of in vitro and in vivo animal models to understand the mechanisms underlying myelinogenesis and neurodegenerative diseases such as multiple sclerosis and autism spectrum disorder, as well as brain tumorigenesis by using endogenous and patient-derived brain or neural tumor models that recapitulate histological and molecular features of human tumors.
We use cutting-edge molecular and cellular approaches (e.g., single-cell multi-omics, functional genomics, and spatial transcriptomics) to dissect how the genetic, epigenetic, and microenvironment controls brain or neural cancer development, recurrence, and metastasis. Our cross-species genomic analyses of human tumors and developing brain tissue at the single cell resolution coupled with genetic mouse modeling have identified a set of glial progenitor-like cells (e.g., Olig2+ pri-OPCs) and “stem-like’ cells (e.g., transitional cerebellar progenitors) as key in the formation of malignant gliomas and medulloblastoma, respectively, pointing to specific cell lineages as the origin of distinct brain tumors, and potential lineage-specific vulnerabilities for targeting distinct subtypes of brain tumors. We are also investigating the tumor microenvironment control of cancer stem cell fitness, tumor recurrence and metastasis by using lineage-traceable model systems for developing effective immunotherapy.
Current projects in Lu Lab aim to:
- Leverage cutting-edge genomic and multi-omics approaches to dissect the brain tumor cells of origin and underlying molecular and signaling pathways that are hijacked and altered during the evolution of brain cancers including glioblastoma, medulloblastoma, ependymoma, and diffuse midline gliomas (DMG / DIPG) (Luo et al., Nature, 2022; Hu et al., Nature Cell Biology, 2023; Weng et al., Cell Stem Cell, 2019; Zhang et al., Cancer Cell, 2019; Lu et al., Cancer Cell, 2016, He et al., Nature medicine, 2014).
- Define transcriptional, signaling, and epigenetic control of myelination and functional nerve regeneration by using in vitro primary neural cell culture, genetically-engineered mice, and pharmacogenomic approaches (Yu et al., Cell, 2013; Wang, et al., Science Advances, 2020; He et al., Nature medicine, 2018; Zhao et al., Dev Cell 2018; He et al., Neuron, 2017; Wang et al., Dev Cell2017; He et al., Nature Neuroscience, 2016).
- Dissect molecular and signaling mechanisms that control Schwann cell myelination in the PNS and the malignant transformation of peripheral nerve sheath tumors (MPNST) by defining the tumor stem-like subpopulation, tumor cell–state evolution and heterogeneity and their regulatory circuitries during NF-to-MPNST transformation (Wu, et al., Science Advances, 2022; Wu et al., Cancer Cell, 2018; Deng et al., Nature communications, 2017; Wu et al., Nature Neuroscience, 2016).
Our research goals comprise dissecting the etiological mechanisms of these neurological diseases and cancers to develop effective therapies respectively through promoting myelin repair and functional nerve regeneration or blocking brain tumorigenesis and recurrence.

Department of Environmental Health
Kettering Lab Complex 110
Office Phone: 513-558-8564
medvedm@ucmail.uc.edu
Lab Home Page
Description of Research:
The research focus of the laboratory is the development of statistical and bioinformatics methods for learning from diverse genomics data types, and the application of such methods through interdisciplinary biomedical efforts. The laboratory leads the LINCS-BD2K Data Coordination Center and Integration Center, which is NIH funded U54 Center jointly funded by the BD2K (Big Data To Knowledge) and LINCS (Library of Integrated Network Based Signatures) programs. Members of the laboratory are also developing protocols for comprehensive data management and the bioinformatics analysis of microarray and next-gen sequencing data generated by the University of Cincinnati Genomics Core. The lab also leads the Bioinformatics Core of the Center for Environmental Genetics (CEG) and participates in several other collaborative biomedical projects.

Department of Pediatrics - Asthma Research
Children's Hospital Building R 236
Office Phone: 513-803-2766
tesfaye.mersha@cchmc.org
CV
Lab Home Page
Description of Research:
Prof. Mersha leads the Population Genetics, Ancestry and Bioinformatics Laboratory (pGAB). His research combines genetic ancestry, bioinformatics, and statistical and functional genomics to unravel genetic and non-genetic contributions to complex diseases in human populations, particularly in allergic disorders. Dr. Mersha's lab long-term goals are to understand and dissect the role of genetic and genetic-modifying causes of asthma and reduce health disparities in children. Current research interests/ approaches of the Mersha Lab include 1.) Ancestry Analysis and Admixture Mapping, 2.) Genome-wide Association Analysis, 3.) RNA-seq Analysis, 4.) Biological Pathways / Networks Analysis, 5.) Multi-Omics Data Integration.

Department of Molecular Genetics
Medical Sciences Building 2206
Office Phone: 513-558-0866
millerwe@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
The Miller laboratory is interested in the mechanisms by which viral pathogens manipulate host cell signal transduction pathways. We are primarily using cytomegaloviruses to examine how the pathogens alter signaling pathways directed by G-protein coupled receptors (GPCRs) to facilitate robust replication in tissues important for host-host dissemination.

Department of Pediatrics - Immunobiology
Children's Hospital Building R
COM Pediatrics Immunobiology - 0054
Office Phone: 513-636-4200
emily.miraldi@cchmc.org
CV
Lab Home Page
Description of Research:
The Miraldi lab’s focus is mathematical modeling of the immune system from high-dimensional genomics measurements. In close collaboration with experimental immunologists, we seek to learn how diverse immune cells sense and respond to their environment in both health and disease. Our studies leverage new biotechnologies (e.g., chromatin accessibility, single-cell genomics measurements) and often require development of new computational methods. The resulting genome-scale models provide unbiased, experimentally testable hypotheses. Long-term, we would like to use these models to re-engineer immune-cell behavior in the context of autoimmunity, cancer and other diseases.

Department of Pediatrics - Translational and Clinical Pharmacology
Children's Hospital Building S2.610
Office Phone: 513-636-0912
tomoyuki.mizuno@cchmc.org
CV
Lab Home Page
Description of Research:
The Mizuno Lab at Cincinnati Children’s utilizes quantitative modeling and simulations, pharmacometrics, pharmacogenetics, and systems pharmacology approaches to develop and implement personalized precision dosing strategies in children and adults.
Most medications on the market come with dosage recommendations for the average patient. However, the optimal dose varies among patients due to substantial variability and complex interactions in patient physiology, drug response, and disease characteristics. Our overarching goal is to optimize drug dosing strategies by predicting drug behaviors, therapeutic efficacy, and disease profiles by using computational models at both population and individual levels.

Department of Pediatrics - Molecular Cardiovascular Biology
Children's Hospital Building R
Office Phone: 513-636-3557
jeff.molkentin@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
Our laboratory investigates a range of focus areas, all of which center on understanding the molecular mechanisms of heart and skeletal muscle disease. Toward this end we study the basic machinery that underlies cell death, with a special interest in mitochondrial-dependent mechanisms of nonapoptotic death (such as cellular necrosis). Prominent diseases of both heart and skeletal muscle are affected by cellular necrosis, so identifying the genes that control this process could have a substantial effect on our treatment of these types of diseases.
We are also interested in characterizing the intracellular signaling pathways that control cellular growth, differentiation and replication in cardiac and skeletal muscle. A better understanding of the signaling pathways that control these processes, coupled with the identification of novel genes, could suggest new treatment strategies for human diseases. Similarly, we are examining the transcriptional regulatory factors and epigenetic mechanisms that regulate cardiac and skeletal muscle differentiation, growth, death and replication, in order to suggest additional targets for treating human disease.
Our laboratory is also actively engaged in identifying novel secreted protein factors in the heart (cytokines, growth factors, chemokines) that might control disease responsiveness. We study the cardiac fibroblast and how it functions during disease to alter the extracellular matrix, which affects heart remodeling. And we are investigating the basic mechanisms of intracellular calcium handling in cardiac and skeletal muscle to further understand the paradigms of excitation-transcription coupling and excitation-signaling coupling.

Department of Pediatrics - Endocrinology
Children's Hospital Building R 609
Office Phone: 513-803-9230
Takahisa.Nakamura@cchmc.org
CV
Lab Home Page
Description of Research:
Our lab’s primary interest is the pathogenesis of obesity and metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). We are specifically interested in molecular mechanisms by which alternations in cellular and circulating RNA networks disrupt systemic glucose and lipid metabolism in the development and progression of these diseases. We have established a variety of mouse and cell culture models to study glucose and lipid metabolism, and miRNA-regulatory machinery in the pathogenesis of obesity. Our goal is to find novel therapeutic approaches targeting RNA networks for treating such diseases.
Our Research interests include:
- Analyzing roles of hepatic miRNA regulatory machinery in the regulation of metabolism in obesity
- Determining endogenous pathogenic dsRNA pathways in chronic inflammation
- Identifying mitochondrial RNA regulating glucose and lipid metabolism
- Investigating circulating RNA that impacts systemic glucose metabolism

Cedars-Sinai Hospital
Children's Hospital Building R
Office Phone: 513-556-3642
anjaparavanda.naren@cshs.org
Publications
Description of Research:
Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel located primarily on the apical surface of epithelial cells that line various organs, including the airways and the gut. CFTR dysfunction is detrimental and may result in life-threatening medical disorders. Dr. Naren's laboratory studies two such disorders; (1) Cystic fibrosis, a lethal genetic disease that affects mostly the Caucasian population (>30,000 in USA), in which the CFTR chloride channel is HY.

Department of Biomedical Engineering
College of Engineering and Applied Science
850 ERC
Office Phone: 513-556-3997
narmond@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
Our laboratory is focused on engineering vascularized tissues through manipulation of the process of angiogenesis, i.e. formation of capillaries.
Potential applications of this research include different areas where therapeutic angiogenesis can be of benefit, including wound healing, heart remodeling and regeneration following myocardial infarction, and repair of ischaemic tissues.

Department of Cancer & Cell Biology
Vontz Center 3312
Office Phone: 513-558-7245
plasd@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
Our group investigates the effects of oncogenic signal transduction on tumor cell metabolism and apoptosis control. In PTEN-deficient cancer cells, signal transduction activates the protein kinase S6K1, which in turn primes cell metabolism to growth and survival in cancer cells. By counteracting oncogenic signal transduction and cancer cell metabolism, we aim to restore normal cell death control in cancer cells.
The lab uses genetic and biochemical approaches to identify and validate novel therapeutic targets in brain cancers and leukemia. We join with outstanding clinical and research colleagues to pursue answers for the biggest obstacles in cancer therapy.

Department of Surgery
Division Chief of General Surgery
Medical Sciences Building SRU Room 1577
Office Phone: 513-558-8467
prittsta@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
General Surgery, Gastrointestinal Surgery, Surgical Critical Care, Trauma Surgery, Sepsis, Inflammation

Department of Pediatrics
Children's Hospital Building R
COM Pediatrics Mol. Cardio. Biology - 0054
Office Phone: 513-517-1221
mattia.quattrocelli@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The Mattia Quattrocelli Lab investigates molecular mechanisms and translatable biomarkers in dysfunction and rescue of striated muscles. The lab aims at combining genetics, epigenetics, and metabolism to garner a deeper understanding of muscle physiology and pharmacology.
An important focus of the lab centers on “precision dosing” for glucocorticoid steroids in heart and muscle regulation. Glucocorticoids (dexamethasone, prednisone, deflazacort) are widely used immunosuppressants and they have a pervasive yet overlooked impact on metabolic homeostasis and striated muscle function. We are currently investigating how repetitive versus pulsatile regimens of these drugs remodel energy production and performance in several contexts of disease, including obesity, unhealthy aging, and heart failure. Moreover, we are leveraging the newly-discovered pharmacological mechanisms to expand the concept of precision dosing for these drugs to “chrono-pharmacology”. In this line of investigation, we are asking what are the circadian and molecular mechanisms governing steroid pharmacology and physiological response in striated muscles.
The overarching goal of the lab is to advance mechanistic understanding and applicable pharmacology to improve the health of heart and muscle.

Department of Computer Science
Old Chemistry Building 819B
CEAS - Computer Science - 0030
Office Phone: 513-556-4752
ralescal@ucmail.uc.edu
Description of Research:
My research centers mainly around machine learning theory and applications. It includes development of algorithms for learning from imbalanced data, context dependent computing, supervised and unsupervised learning, feature selection, support vector machines, quantum computing and learning. At the application level I am interested in image understanding, brain computer interface, and malware detection.
Department of Psychiatry & Behavioral Neuroscience
One Stetson Square
COM Psychiatry Volunteer Faculty - 0559
Office phone 513-558-7700
lramsey@cmh.edu
Lab Home Page

Department of Internal Medicine
Cardiovascular Research Center 3926
Office Phone: 513-558-3062
rubinsjk@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
The Rubinstein laboratory has been at the forefront of understanding the roles of the TRPV channels in regulating cardiac function with specific attention to TRPV2 channels in modulating contractility and TRPV1 channels in ischemic preconditioning. The laboratory has also worked on several translational science projects with basic researchers.

Department of Internal Medicine
Cardiovascular Research Center 3923
Office Phone: 513-558-7498
sadayasl@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
The long-term goal of the Sadayappan Lab involves 1) elucidating the causes of muscle-specific diseases at the molecular level and 2) identifying therapeutic targets that will lead to the development of effective cures. The more specific objectives involve determining the up- and downstream regulators of sarcomere structure and function of both cardiac and skeletal muscles in health and disease.

Department of Pediatrics
Children's Hospital Building R
Office phone 513-556-3642
nathan.salomonis@cchmc.org
CV
Lab Home Page
Description of Research:
The role of alternative splicing in mammalian development and disease is profound. Unique alternative mRNA isoforms dictate opposing transcriptional, signaling, and cell survival responses. These molecular switches can drive differentiation into new lineages or modulate the effectiveness of chemotherapy. While the research community has made significant strides understanding the role of isoform regulation in diseases such as cancer, its broader impact on lineage decisions, tumor survival, and immune responses remains largely undefined.
The Salomonis lab is pioneering the use of artificial intelligence (AI) to investigate tumor evolution and normal cell development at an unprecedented scale. Our work aims to define the precise role of RNA isoform regulation in cancer, understand which cells and how these programs emerge and to exploit such findings for the creation of new therapies. To address these challenges, our team has developed advanced software ecosystems, cell atlases and web platforms to enable new discoveries. Our tools include the highly used AltAnalyze workflow for alternative splicing and single-cell analysis, scTriangulate to automate cell atlas creation from diverse single-cell modalities or prior knowledge and Splicing Neoantigen Finder (SNAF) to define new shared targets for cancer therapy. Our approaches leverage exciting new advances in long-read single-cell analysis, spatial transcriptomics, deep learning, Bayesian modeling and rigorous experimental validation with our collaborative partners. With these approaches in hand, we aim create new cellular and immunotherapies, characterize disease-specific cell states, and unravel the complexities of clonal evolution.

Department of Radiation Oncology
UC Barrett Cancer Center
3151 Bellevue Avenue
Cincinnati, OH 45219
Office Phone: 513-584-5668
vinita.takiar@uchealth.com
Publications
CV
Lab Home Page
Description of Research:
mechanisms by which tumors recur despite aggressive treatment. The laboratory also participates in the translational elements of clinical trials in order to better understand the basic biology behind the outcomes being observed in the clinic.
The overall goal of the laboratory is to better understand how tumor cells evade or resist cell death by anti-cancer therapy. If these mechanisms were better understood, then potentially clinical treatment could be better tailored to each patient.
One focus of the laboratory is on identifying mechanisms of adaptive resistance to radiation therapy. For this project, we use Reverse Phase Protein Microarray Analysis (RPPA) as well as cellular and mouse models to try and replicate the human host. Select therapies are then tested alone and in combination with ionizing radiation in a strategic manner to identify new combinations of treatment that may be more effective than those currently available.
Another focus of the laboratory is on better understanding the mechanisms underlying resistance to immunotherapy, including T-cell dysfunction, and the potential role of NK cells and the microenvironment. Currently, immunotherapy is indicated for patients in the recurrent or metastatic setting for head and neck cancer, and although those who respond to treatment have terrific outcomes, the majority of patients do not respond. The goals of this project are to be able to better identify patients most likely to respond to treatment and to understand how to turn a non-responder into a responder to potentially design subsequent human trials that will improve immunotherapy effectiveness.

Department of Pediatrics - Division of Translational and Clinical Pharmacology
Children's Hospital
Office Phone: 513-373-0238
zachary.taylor@cchmc.org
Publications
CV
Description of Research:
My work focuses on developing and implementing personalized drug dosing strategies for pediatric patients. The scope of my research includes understanding and applying pharmacokinetic (PK), pharmacodynamic (PD), pharmacometric (PMx) and pharmacogenetic (PGx) approaches to develop and implement model-informed precision dosing (MIPD).
Through my research, I seek to describe a drug's metabolism and response through quantitative methods, creating translational tools that enable optimized drug dosing strategies and improve therapeutic outcomes for pediatric patients.

Department of Molecular Genetics
Medical Sciences Building 2204
Office Phone: 513-558-6246
thompstb@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
Cues to direct cellular programs are executed by protein signaling molecules such as that of the Transforming Growth Factor b family. Disruption of these programs are a leading cause of numerous human pathologies including cancer and fibrosis. Thus, efforts are aimed at rebalancing signaling programs can offer therapeutic opportunities for treatment. By using a combination of structural biology (E.g. cryoEM and X-ray crystallography), artificial intelligence and bioengineering we are making the next generation of therapeutics that can modulate ligands of the TGF-b family.

Department of Pediatrics - Neurology
Children's Hospital Bldg R
COM Pediatrics Neurology - 0054
Lubov.Timchenko@cchmc.org
CV
Description of Research:
Molecular pathobiology and development of therapies for adult and congenital forms of neuro-muscular disease myotonic dystrophy type 1 and myotonic dystrophy type 2; the role of toxic RNAs containing long repeats in regulation of gene expression; skeletal muscle

Department of Cancer & Cell Biology
Vontz Center 2328
Office Phone: 513-558-8675
waltzse@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
The Waltz laboratory is interested in the molecular mechanisms by which cell-surface receptor tyrosine kinases and growth factors control human disease processes, with a special emphasis on mechanisms regulating cancer growth and metastasis, and inflammation. The Waltz group has made several seminal discoveries related to the Ron receptor tyrosine kinase in both breast and prostate cancers. In particular, the laboratory has shown that Ron overexpression specific to the breast epithelium is sufficient to induce aggressive breast cancers that are highly metastatic. In addition, the Waltz group has found that Ron is an important contributing factor controlling the growth of prostate cancers through the regulation of tumor angiogenesis (blood vessel formation). The immediate goals for these projects are to understand the physiological signaling pathways that control the aggressive tumor phenotype downstream of Ron signaling. Future studies will involve the utilization of in vivo gene-targeted murine models to study disease progression as well as the isolation and analysis of primary epithelial and stromal cells from the breast and prostate environments. In addition, the laboratory plans to use orthotopic transplantation of gene-modified cell lines into syngeneic models to explore these signaling pathways in detail.
With respect to control of cellular inflammation, the Waltz laboratory has also shown that Ron is expressed on select macrophage populations, and that signaling through this receptor negatively regulates the balance of cytokine and chemokine production during acute tissue injury in vivo. This critical balance of immune mediators is essential to control the body's response to injury, wounding, and infection. To analyze the mechanisms responsible for the Ron-dependent regulation of cytokine/chemokine production, the laboratory utilizes co-culture systems composed of primary tissue macrophages and epithelial cells from select gene knockout animals to dissect the role of macrophages in tissue injury.
The overall goal of the Waltz laboratory is to examine the Ron signaling pathway as a novel therapeutic target in the regulation of a variety of human diseases.

Department of Pathology & Laboratory Med
Cardiovascular Research Center 1933
COM Pathology Wang Lab - 0529
wanyy@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
Dr. Wang's research over the past two decades has focused on cardiovascular pathophysiology and therapies, with three primary areas of concentration: 1) studying the impact of various additive agents in cardioplegic solutions on functional cardiac restoration, 2) investigating ischemic preconditioning as a protective mechanism against ischemia/reperfusion injury, including its molecular mechanisms and signaling pathways, and 3) advancing progenitor/stem cell-based therapy for treating myocardial infarction.
Currently, Dr. Wang's research team delves into progenitor/stem cell biology, with a particular emphasis on pluripotency, differentiation, proliferation, and survival. Their aim is to enhance the regenerative potential of adult heart tissue following myocardial infarction (MI). Through innovative CRISPR-induced cell manipulation techniques, they have successfully generated cardiovascular progenitor cells (CPCs) exhibiting clonality, self-renewal, and cardiac tri-potentiality. These CPCs have shown promising results in improving heart function and reducing scar formation in MI mice upon transplantation. Dr. Wang's team is also developing a viral or non-viral CRISPR approach to activate endogenous genes for CPC generation from fibroblasts, with a focus on identifying long non-coding RNAs (lncRNAs) crucial for epigenetic remodeling during cell reprogramming. Additionally, their research explores the roles of transcription factors, microRNAs, and growth factors in optimizing conditions for cardiomyocyte regeneration. Notably, they have identified microRNA-128 as a pivotal regulator of cardiomyocyte proliferation, offering a novel therapeutic avenue for heart repair. Dr. Wang's research has gained notable recognition in esteemed cardiovascular journals, underscoring their substantial expertise in cardiovascular research and previous experience as a cardiovascular and thoracic surgeon. This wealth of knowledge, combined with adeptness in both animal models and human surgeries, uniquely equips Dr. Wang to pioneer advancements in myocardial repair strategies through progenitor/stem cell-based therapy in ischemic environments.

Department of Pediatrics
Children's Hospital Building R
COM Pediatrics Hematology - 0054
Office Phone: 513-803-4597
russell.ware@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
The Ware Lab team focuses on translational hematology research to improve our overall understanding of sickle cell disease with the long-term goal of improving the lives of affected children. Specific areas of laboratory focus include the identification and validation of genetic modifiers, optimizing the use of hydroxyurea, investigating the safety of long-term hydroxyurea treatment, and elucidating the phenotypic variability of drug responses through investigation of the pharmacokinetics, pharmacodynamics and pharmacogenomics of hydroxyurea. The lab performs a wide variety of laboratory techniques including genetic / genomic studies, gene expression profiling and functional analyses. DNA, serum / plasma and urine samples are analyzed from multiple clinical trials, including ones conducted in the United States as well as in the global arena.
Russell E. Ware, MD, PhD, has a strong interest in global health and especially for children with sickle cell disease who live in developing countries within the Caribbean and sub-Saharan Africa. He has designed and completed collaborative surveillance programs for sickle cell disease in Angola, Uganda, Tanzania and Malawi. He has conducted clinical trials in Jamaica (EXTEND) and in the Dominican Republic (SACRED) evaluating the effectiveness of therapies used for children who have sickle cell disease coupled with factors indicating a higher stroke risk. Additionally, Dr. Ware has established studies designed to safely introduce hydroxyurea into sub-Saharan Africa: Realizing Effectiveness Across Continents with Hydroxyurea (REACH), Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM), and Prospective Identification of Variables as Outcomes for Treatment (PIVOT).

Department of Pediatrics
CCHMC S Building
Molecular Cardiovascular Biology
Office Phone: 513-636-7232
joshua.waxman@cchmc.org
Publications
CV
Lab Home Page
Description of Research:
Congenital heart defects are among the most common birth defects. Thus, understanding the underlying molecular nature of these defects is a major priority in cardiac research. Our lab investigates the selection of progenitor cells, a developmental process that establishes the heart’s size.
The ultimate fate of organ progenitors depends upon a balance of both inductive and restrictive signals. Because the same signals affecting the formation of cardiac progenitors in embryos are used by cardiac stem cells, our studies will have implications for understanding stem cell differentiation and cardiac regeneration.
Ultimately, we think that our elucidation of the mechanisms restricting cardiac progenitors will lead to a greater understanding of congenital heart defects, and will also have the potential to positively affect our ability to develop novel therapies aimed at healing injured hearts in children and adults.

Department of Pediatrics
Children's Hospital Building R
Office Phone: 513-803-9078
matthew.weirauch@cchmc.org
CV
Lab Home Page
Description of Research:
The control of when and where genes are utilized is a major component driving phenotypic differences between organisms and individuals. In our lab, we use computational methods to study how, when, where, and why genes are “turned on and off”. To this end, we study transcription factors, which interact with the genome by binding to short sequences proximal to the genes they control. Humans have 1500 different transcription factors, each of which recognizes different short sequences, or “motifs”, within the genome. We develop methods for determining transcription factor motifs, integrating these motifs with other information to predict transcription factor binding, and understanding the regulatory mechanisms underlying human diseases.

Department of Pediatrics - Pulmonary Biology
Children's Hospital Building R
Office Phone: 513-636-7665
jeffrey.whitsett@cchmc.org
CV
Lab Home Page
Description of Research:
Dr. Whitsett is internationally known for his research in pulmonary medicine and his clinical expertise in neonatology. Dr. Whitsett has made groundbreaking contributions to pulmonary medicine and biology in his studies of the surfactant proteins A, B, C, and D, cloning their genes and clarifying their roles in lung development and function. Throughout his career, Dr. Whitsett has transitioned from molecular biology to animal models and then to the diagnosis and therapy of human disease. Notably, he has played a critical role in making surfactant protein replacement routine in the treatment of immature lungs and respiratory distress syndrome in premature infants. Notably, his laboratory has contributed to the identification of a number of genes critical for lung formation and function and shown that mutations in genes regulating surfactant homeostasis are responsible for acute and chronic lung disease in infants and adults. Dr. Whitsett is the author of over 600 basic science and clinical literature papers.
Our laboratory discovered surfactant proteins B and C, cloned the genes encoding the surfactant proteins A, B, C, and D, Scgb1a1, TTF-1, and others, and utilized transgenic mouse models to delete and mutate these genes in transgenic mice. We identified transcriptional networks regulating lung morphogenesis and perinatal lung maturation contributing to the understanding of the roles of TTF-1, CEBPα, SOX2, SOX17, FOXA1, FOXA2, FOXA3, FOXF1, SPDEF, KLF5, CDC42, GATA6 and Hippo/YAP using both in vitro and in vivo methods. We identified multiple transcription factors regulating goblet cell differentiation in airway epithelial cells, including novel roles for SPDEF and FOXA3 in airway goblet cells controlling innate immunity in the lung. We produced transgenic mouse models for conditional deletion and expression of genes involved in lung development, disease, and repair, including mouse models of pulmonary adenocarcinoma and pulmonary alveolar proteinosis (PAP). We utilized RNA-Seq, microarray, Chip-Seq, and ATAC-Seq in the application of Next-Gen sequencing and bioinformatics to identify and understand the cellular and molecular networks involved in the regulation of lung development and disease using clinical samples, in vitro and in vivo models.
Department of Molecular Genetics
2939 Cardiovascular Center
231 Albert Sabin Way
Office Phone: 513-558-0058
wieczodf@ucmail.uc.edu
CV
Lab Home Page
Description of Research:
Our research interests lie in the understanding of muscle contractile proteins associated with both normal and diseased function. More specifically, we focus on tropomyosin, a sarcomeric thin filament protein found in skeletal and cardiac muscle. Our research addresses the physiological significance of tropomyosin (Tm) isoforms with respect to sarcomeric function and their role in cardiac disease. Our approach utilizes transgenic and knockout mice to determine how the cardiac sarcomere and the heart undergo remodeling in response to different Tm isoforms and genetically-defined mutations that correspond to human hypertrophic and dilated cardiomyopathies. Our recent work examines how Tm phosphorylation influences sarcomeric performance and cardiac function, along with the molecular pathways that are activated by this process.

Department of Internal Medicine - Pulmonary
Medical Sciences Building
Room 7165
231 Albert Sabin Way
Office Phone: 513-558-6246
yuj9@ucmail.uc.edu
Publications
CV
Lab Home Page
Description of Research:
I lead a research laboratory focusing on investigation of the role of tumor suppressor proteins tuberin (TSC2) and hamartin (TSC1) in steroid action, cell survival, cellular metabolism, tumorigenesis and metastasis, and signaling transduction pathways. My laboratory also develops animal models to test the efficacy of FDA approved drugs on the progression and metastasis of mTORC1 hyperactive cells, lung inflammation and injury. Current studies include determining the role of estrogen in the progression of lymphangioleiomyomatosis (LAM), a female predominant rare lung disease, from the alteration of signaling pathways, to the integrity of alveolar epithelium and microenvironment in the lung, and to the pulmonary functions. We are also investigating the potential application of using bloodbased biomarkers in LAM. Our research has been funded by NIH/the National Heart, Lung and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Department of Defense and the LAM Foundation. My laboratory developed the first LAM-associated, patient-derived primary cell line and the first metastatic model of LAM. We also have identified mTORC1-independent but mTORC2-mediated activation of prostaglandin biosynthesis in TSC and LAM, and used metabolomics profiling to identify dysregulation of glucose metabolism and pentose phosphate pathway addiction in TSC2-deficient cells.

Department of Anesthesiology
Medical Sciences Building 3413
Office Phone: 513-558-2427
zhangj4@ucmail.uc.edu
CV
Description of Research:
Chronic pain conditions such as neuropathic pain are very common and can last a lifetime, persisting long after the initial damage to the nerve has healed. Chronic pain conditions involve complex, orchestrated changes in the sensory neurons and their synaptic targets. These changes include abnormal electrical activity, alterations in ion channels and transmitters, and sensitization of the pain pathways in the spinal cord and brain. We are currently investigating the role of cytokines in pain. We have developed new animal models involving compression and/or inflammation of the sensory ganglia. These models are particularly relevant to understanding low back pain. We have found that several inflammatory cytokines are upregulated in these models, with a time course that parallels the development of pain behaviors. Our aim is to understand the possible causal roles of these cytokines in abnormal pain states, with the ultimate goal of identifying new therapeutic targets for chronic pain. We use a number of techniques, including electrophysiology, animal behavior, microscopy, and biochemical and molecular methods. In a related project, we are also investigating the role and causes of the abnormal sympathetic sprouting into the sensory ganglia that exacerbates many chronic pain states and how sympathetic regulate local immune/inflammatory responses. Recently, we have started several new projects: 1) determine how microvascular responses in the dorsal root ganglia triggers neuropathic spontaneous pain; 2) relationship between nerve injury initiated regeneration and the persistence of neuropathic pain; 3) how steroid receptors change under pathological conditions and how such changes may affect therapeutic efficacy of steroids used for managing inflammatory pain conditions. Lastly, we have initiated several clinical studies to translate preclinical findings to clinical practice. Specifically, we are interested in whether extended nerve block provides additional benefit for patients with traumatic injury in lowing the risk of chronic pain; and how to improve efficacy of epidural steroids for managing low back pain.

Department of Pediatrics - Critical Care
Children's Hospital Building R 033
Office Phone: 513-636-8704
basilia.zingarelli@cchmc.org
CV
Lab Home Page
Description of Research:
The Zingarelli Laboratory is focused on the investigation of the pathophysiologic mechanisms of sepsis, trauma and hemorrhagic shock, which are leading causes of morbidity and mortality in intensive care units. A particular goal of her research has been to define the mechanisms of metabolic recovery and innate immune responses mediated by the nuclear hormone receptors peroxisome proliferator activated receptors (PPARs) and by the AMP activated protein kinase (AMPK), which are major regulators of the glucose and lipid metabolism. In dissecting the dysmetabolic mechanisms of organ injury, the Zingarelli laboratory has discovered that key molecules of the mitochondrial retrograde signaling, such as humanin, may contribute to the regulation of metabolic recovery of damaged organs. Research efforts also focus on understanding the role of aging on the clinical course of infections, severe hemorrhage and trauma. The laboratory employs a multidisciplinary approach combining in vivo and in vitro experimental models in genetically modified rodents and cell lines. These models are also utilized as a translational research platform to screen novel pharmacological compounds that can modulate the molecular mechanisms of organ function. The goal is to identify specific therapeutic interventions for pediatric, adult and elderly patients.
The Zingarelli Laboratory is also collaborating with several basic science and translational studies at Cincinnati Children’s Hospital. In collaboration with Takahisa Nakamura, PhD of the Division of Endocrinology and Jennifer Kaplan, MD, MS, of the Division of Critical Care Medicine, the Zingarelli Laboratory explores critical pathways of cell signaling and reprogramming of innate immune responses through release of extracellular vesicles in obesity and sepsis.
Ongoing projects are primarily funded by multiple grants from the National Institutes of Health.
Expand all
Collapse all
Contact Us
Pharmacology, Physiology PhD ProgramsUniversity of Cincinnati
PO Box 670576
Cincinnati, OH 45267-0576
Ms. Jeannie Cummins
Program Coordinator
Phone: 513-558-3102
Email:jeannie.cummins@uc.edu